Michael Steele, former RNC Chairman and Dahlia Lithwick Senior Editor of Slate joins Nicolle Wallace on Deadline White House to discuss Donald Trump’s moves to dismantle federal agencies and the ...
Michael Clark, President of Society of former Special Agents of the FBI joins Nicolle Wallace on Deadline White House to discuss the growing fears of the Trump Administration purging the FBI, and the ...
Former second gentleman Doug Emhoff took a job from the law firm Willkie Farr & Gallagher LLP after former Vice President ...
The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is halting shipments to the world’s second-most populous country.
For the recently completed fourth quarter, Merck booked an adjusted profit of $1.72 per share on $15.6 billion in revenue. Sales of top-selling cancer treatment Keytruda climbed 19% to $7.84 billion.
Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.
Merck’s Q4 sales rose 7% YoY to $15.62B, slightly beating the $15.49B consensus. Adjusted EPS jumped to $1.72, topping estimates of $1.62. Keytruda sales grew 19% YoY to $7.84B, while Gardasil ...
The latest release from Aardman Studios, Wallace & Gromit: Vengeance Most Fowl, marks a major first for the franchise, bringing back an old villain to wreak revenge on the titular two. Created by ...
Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck faces broader industry pressure as vaccine skeptic Robert F. Kennedy Jr. possibly next ...
Merck (MRK) stock was mangled today after the pharmaceutical and vaccine company released its guidance for 2025. The company expects adjusted earnings per share for the year to range from $8.88 to ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Merck shares tumbled after the drugmaker said it was halting shipments of a top-selling vaccine to China to ...